ACE and benign prostatic hyperplasia: Treatment with the ACE inhibitor enalaprilat, which does not readily cross the blood-brain barrier (BBB), caused a 4-fold greater depressor response in BPH/2J than BPN/3J mice (Jackson et al., 2013).